NCT02796118View on ClinicalTrials.gov

Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy Subjects
Interventions
DRUG

ASP2151

Oral

DRUG

Placebo

Oral

Trial Locations (1)

Unknown

Site JP00001, Osaka

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY